Published April 2021 | Version v1
Journal article

Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models

  • 1. Department of Radiology, Mayo Clinic, Rochester, MN (United States)
  • 2. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN (United States)
  • 3. Division of Anatomic Pathology, Mayo Clinic, Rochester, MN (United States)
  • 4. Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN (United States)

Description

To determine the potential of bi-parametric dual-frequency hepatic MR elastography (MRE) for predicting portal pressure (PP) in mouse models of portal hypertension (PHTN) with the presence of varying hepatic fibrosis. We studied 73 wild-type male mice, including 22 mice with hepatic congestion, 20 mice with cholestatic liver injury, and 31 age-matched sham mice. Hepatic shear stiffness (SS) and volumetric strain (VS) were calculated by 3D MRE acquired at 80 and 200 Hz. We measured PP immediately after MRE. Liver fibrosis was verified by hydroxyproline assay. We predicted PP by fitting generalized linear models with single- and dual-frequency SS and VS, respectively. The relationship between predicted and actual PP was evaluated by Spearman's correlation. We compared the prediction accuracy of portal hypertension for all models with DeLong tests at a significance level of 0.05. Animals with congestive or cholestatic liver disease developed significant PHTN and hepatic fibrosis to varying degrees. In both models, SS increased, while VS decreased significantly compared with shams. All bi-parametric models had high diagnostic accuracy for PHTN. The dual-frequency models (AUCs: 0.90 [81-95%], 0.91 [81-95%]) had substantially or significantly higher accuracy than single-frequency ones (AUCs: 0.83 [71-91%], and 0.78 [66-87%]). The predicted PP of dual-frequency models also showed stronger correlations with actual PP than single-frequency predictions. The bi-parametric dual-frequency model improved the diagnostic accuracy of liver MRE in diagnosing PHTN in preclinical models. This technical advance has the potential to monitor PHTN progression and treatment efficacy in the presence of varying fibrosis.

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
31
Journal Issue
4
Journal Page Range
p. 2303-2311
ISSN
0938-7994
CODEN
EURAE3